Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Mar
12
Today In Oncology
Early Study Evaluates Two-Vaccine Strategy in T-Cell Lymphoma
Structured Exercise Plan for Patients With Cancer May Reduce Cognitive Effects of Chemotherapy
Risk of Breast Cancer After Ovarian Cancer in Women With BRCA1/2 Variants
Metastatic Uveal Melanoma Nivoluma and Ipilimumab Plus Percutaneous Hepatic Perfusion
FDA Releases Updated Guidance on Biosimilar Development
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo